Entecavir, FTC, L-FMAU, LdT and others

被引：24

作者：

Buti, M ^{[1
]}

Esteban, R ^{[1
]}

机构：

[1] Hosp Gen Univ Vall Hebron, Liver Unit, Barcelona 08035, Spain

来源：

JOURNAL OF HEPATOLOGY | 2003年 / 39卷

关键词：

D O I：

10.1016/S0168-8278(03)00316-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S139 / S142

页数：4

共 24 条

[1]

Aguesse-Germon S, 1998, ANTIMICROB AGENTS CH, V42, P369

[2] Antiviral drugs [J].

Balfour, HH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) :1255-1268

[3] HEPATITIS-B VIRUS IMMUNOPATHOGENESIS [J].

CHISARI, FV ;

FERRARI, C .

ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 :29-60

[4] Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection [J].

Colonno, RJ ;

Genovesi, EV ;

Medina, I ;

Lamb, L ;

Durham, SK ;

Huang, ML ;

Corey, L ;

Littlejohn, M ;

Locarnini, S ;

Tennant, BC ;

Rose, B ;

Clark, JM .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10) :1236-1245

[5] Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection [J].

de Man, RA ;

Wolters, LMM ;

Nevens, F ;

Chua, D ;

Sherman, M ;

Lai, CL ;

Gadano, A ;

Lee, Y ;

Mazzotta, F ;

Thomas, N ;

DeHertogh, D .

HEPATOLOGY, 2001, 34 (03) :578-582

[6]

Hayden Frederick, 2001, GOODMAN GILMANS PHAR, P1313

[7] Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection [J].

Lai, CL ;

Rosmawati, M ;

Lao, J ;

Van Vlierberghe, H ;

Anderson, FH ;

Thomas, N ;

Dehertogh, D .

GASTROENTEROLOGY, 2002, 123 (06) :1831-1838

[8]

Lai CL, 2001, HEPATOLOGY, V34, p321A

[9] Characterization of the antiviral effect of 2′,3′-dideoxy-2′, 3′-didehydro-β-L-5-fluorocytidine in the duck hepatitis B virus infection model [J].

Le Guerhier, F ;

Pichoud, C ;

Guerret, S ;

Chevallier, M ;

Jamard, C ;

Hantz, O ;

Li, XY ;

Chen, SH ;

King, I ;

Trépo, C ;

Cheng, YC ;

Zoulim, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :111-122

[10]

Leung N, 2001, HEPATOLOGY, V34, p349A

← 1 2 3 →